Old Web
English
Sign In
Acemap
>
authorDetail
>
C Abletshauser
C Abletshauser
Medicine
Internal medicine
Endocrinology
Diabetes mellitus
Fluvastatin
6
Papers
11
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Time-of-intake (morning versus evening) of extended-release fluvastatin in hyperlipemic patients is without influence on the pharmacodynamics (mevalonic acid excretion) and pharmacokinetics
2007
CP | Principles and Practice of Constraint Programming
G. Fauler
C Abletshauser
W. Erwa
R. Löser
Witschital K
Winfried März
Show All
Source
Cite
Save
Citations (8)
M.510 Fluvastatin ER formulation reduces cholesterol biosynthesis independent of daytime of administration
2004
Atherosclerosis Supplements
G. Fauler
Winfried März
C Abletshauser
W. Erwa
R. Löser
Show All
Source
Cite
Save
Citations (1)
1P-0020 Patients with ischemic heart disease show benefit with fluvastatin therapy during 48-h ambulatory ECG
2003
Atherosclerosis Supplements
T. Von Arnim
C Abletshauser
Show All
Source
Cite
Save
Citations (0)
EFFECTS OF THE ANGIOTENSIN-II-ANTAGONIST VALSARTAN ON BLOOD LIPIDS AND GLUCOSE IN HYPERTENSIVE PATIENTS: P2.6
2000
Journal of Hypertension
M. Hanefeld
C Abletshauser
Show All
Source
Cite
Save
Citations (0)
1.P.210 Lowering of LDL-cholesterol improves endothelial function by increased nitric oxide synthase activity
1997
Atherosclerosis
Roland E. Schmieder
Stefan John
Markus P. Schlaich
M. R. W. Langenfeld
Gottfried Weidinger
C Abletshauser
Hans P. Schobel
Show All
Source
Cite
Save
Citations (0)
1